Aravive, Inc. Research and Development Expense (Excluding Acquired in Process Cost)
Aravive, Inc. reported Research and Development Expense (Excluding Acquired in Process Cost) of $8.73 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2023-11-09
- Aravive, Inc. research and development expense (excluding acquired in process cost) for the quarter ending 2023-09-30 was $8.73M, a 53.24% decline year-over-year.
- Aravive, Inc. research and development expense (excluding acquired in process cost) for the quarter ending 2023-06-30 was $10.79M, a 37.68% decline year-over-year.
- Aravive, Inc. research and development expense (excluding acquired in process cost) for the quarter ending 2023-03-31 was $15.91M, a 22.40% increase year-over-year.
- Aravive, Inc. research and development expense (excluding acquired in process cost) for the quarter ending 2022-12-31 was $17.95M, a 47.23% increase year-over-year.
- Aravive, Inc. research and development expense (excluding acquired in process cost) for fiscal 2022 was $66.94M, a 78.31% increase from fiscal 2021.
- Aravive, Inc. research and development expense (excluding acquired in process cost) for fiscal 2021 was $37.54M, a 113.06% increase from fiscal 2020.
- Aravive, Inc. research and development expense (excluding acquired in process cost) for fiscal 2020 was $17.62M, a 37.27% increase from fiscal 2019.
- Aravive, Inc. research and development expense (excluding acquired in process cost) for fiscal 2019 was $12.84M, a 15.90% increase from fiscal 2018.
| Period end | Research and Development Expense (Excluding Acquired in Process Cost) 3 month | Research and Development Expense (Excluding Acquired in Process Cost) 6 month | Research and Development Expense (Excluding Acquired in Process Cost) 9 month | Research and Development Expense (Excluding Acquired in Process Cost) 12 month |
|---|---|---|---|---|
| 2023-09-30 | $8.73M 10-Q · filed 2023-11-09 | $19.52M derived: sum of 2 quarters · filed 2023-11-09 | $35.44M 10-Q · filed 2023-11-09 | $53.39M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $10.79M 10-Q · filed 2023-08-21 | $26.70M 10-Q · filed 2023-08-21 | $44.66M derived: sum of 3 quarters · filed 2023-08-21 | $63.33M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $15.91M 10-Q · filed 2023-05-10 | $33.87M derived: sum of 2 quarters · filed 2023-05-10 | $52.54M derived: sum of 3 quarters · filed 2023-11-09 | $69.85M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $17.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $36.62M derived: sum of 2 quarters · filed 2023-11-09 | $53.94M derived: sum of 3 quarters · filed 2023-11-09 | $66.94M 10-K · filed 2023-03-15 |
| 2022-09-30 | $18.67M 10-Q · filed 2023-11-09 | $35.98M derived: sum of 2 quarters · filed 2023-11-09 | $48.98M 10-Q · filed 2023-11-09 | $61.18M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $17.32M 10-Q · filed 2023-08-21 | $30.32M 10-Q · filed 2023-08-21 | $42.51M derived: sum of 3 quarters · filed 2023-08-21 | $53.85M derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | $13.00M 10-Q · filed 2023-05-10 | $25.20M derived: sum of 2 quarters · filed 2023-05-10 | $36.54M derived: sum of 3 quarters · filed 2023-05-10 | $44.66M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $12.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $23.54M derived: sum of 2 quarters · filed 2023-03-15 | $31.66M derived: sum of 3 quarters · filed 2023-03-15 | $37.54M 10-K · filed 2023-03-15 |
| 2021-09-30 | $11.34M 10-Q · filed 2022-11-10 | $19.46M derived: sum of 2 quarters · filed 2022-11-10 | $25.35M 10-Q · filed 2022-11-10 | $31.88M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $8.12M 10-Q · filed 2022-08-11 | $14.00M 10-Q · filed 2022-08-11 | $20.54M derived: sum of 3 quarters · filed 2022-08-11 | $25.61M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $5.88M 10-Q · filed 2022-05-12 | $12.42M derived: sum of 2 quarters · filed 2022-05-12 | $17.49M derived: sum of 3 quarters · filed 2022-05-12 | $20.01M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $11.61M derived: sum of 2 quarters · filed 2022-03-31 | $14.13M derived: sum of 3 quarters · filed 2022-03-31 | $17.62M 10-K · filed 2022-03-31 |
| 2020-09-30 | $5.07M 10-Q · filed 2021-10-28 | $7.59M derived: sum of 2 quarters · filed 2021-10-28 | $11.09M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $2.52M 10-Q · filed 2021-08-05 | $6.01M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $3.49M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $12.84M 10-K · filed 2021-03-16 | |||
| 2018-12-31 | $11.07M 10-K · filed 2020-03-27 |